Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.7.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.7.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GN.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JH.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JH.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JH.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GJ.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GJ.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GJ.1.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GJ.1.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HN.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HN.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.10.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.10.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.10.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.41.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.41.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.41.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GW.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GW.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JG.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JG.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JG.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCKNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCKNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCKNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GN.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GN.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.27NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.27NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GY.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used